Abstract
The phenotypic expression in familial adenomatous polyposis (FAP) is variable. This study compares colectomy specimens was 4000 (interquartile (IQ) range 3000-4875), compared with 600 (IQ range 488-1400) in the 61 matched patients.
Colon polyps were also numerous with a 1 bp insertion at codon 1323 or a 1 bp deletion at 1407, and when there was a 1 bp substitution (resulting in a stop codon) at codon 233. Other mutations were associated with far fewer colonic polyps.
There was an apparent excess of desmoid tumours when there was a 5 bp deletion at codon 1309; closer examination, however, shows one family of 12 members with sufficient risk factors, including multiple surgery and pregnancies, had no desmoid disease. Extracolonic cancers were also common with the mutation at codon 1309 (p=0003, Fisher's exact test).
Discussion
Nagase et a14 suggested that truncation of the APC gene product in the region of the deletion between codon 1255 and codon 1467 (which results in a premature stop codon downstream from the deletion by frame shift) results in a profuse type of polyposis. Patients in this study with deletions between these two codons similarly have a high polyp density, as do four family members with a 1 bp substitution at codon 233. Colonic polyp count clearly shows a bimodal distribution not consistent with any particular region of the APC gene and the conclusion made by Nagase et al seems over simplified.
The presence of other phenotypic expressions varies between patients with the same mutation. Upper gastrointestinal polyps do not seem more frequent when there is a deletion between codons 1255 and 1467, and desmoid disease is similarly variable. Although there was an apparent excess of demoid disease within the seven families with a 5 bp deletion at codon 1309, only one of 12 patients within one of the families had desmoid disease. This family may be less susceptible to desmoid disease because of a protective modifier locus cosegregating within this family. Other extracolonic malignancies also seem particularly frequent at codon 1309.
These findings suggest that there may be a correlation between a specific germline mutation and the number of large bowel polyps. Phenotypic expression in patients with the same mutation varies, however, therefore not all clinical variation is caused by a particular APC gene mutation. The residual heterogeneity in phenotypic expression may be influenced by other genes, specific environmental factors or chance.
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